In tumor cells, myricetin has been shown to be proapoptotic by downregulation of c-Myc in ovarian tumor cells [150], and, as is known, c-Myc directs malignant tumor progression by Nrf-2 [151]. The gene discussed is NFE2L2; the disease is neoplasm.